System enables IRB members to review ?s in near real-time from anywhere in the world
System enables IRB members to review AEs in near real-time from anywhere in the world
GlobalView EventNet
PPD, Inc. (Wilmington, NC) just released a customizable, global event management and adjudication system for quick review of safety and endpoint-driven data from large clinical trials or registries. The secure, Internet-based system provides broad access to adverse event data, particularly in studies with multiple information sources and ones that need review by a board of independent physicians.
GlobalView EventNet provides access to data in near real-time and allows IRB members to examine the data at their own convenience from any location around the world. The board members can also request follow-up information or confirm adjudicated events through an online interface. GlobalView EventNet also sends automatic email alerts to prompt and encourage timely review. The system electronically compares each IRB member's decision and documents them per established guidelines.
PPD, Inc., (910) 251-0081, www.ppdi.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Oveporexton Shows Superior Efficacy in Phase II Narcolepsy Type 1 Trial Without Hepatotoxicity
May 16th 2025In the TAK-861-2001 Phase IIb study, oveporexton significantly improved wakefulness, daytime sleepiness, and cataplexy frequency in patients with narcolepsy type 1, outperforming current therapies and avoiding liver toxicity seen with earlier OX2R agonists, according to results published in The New England Journal of Medicine.